Travere Therapeutics, Inc. · NASDAQ:TVTX
Dube Eric M sold 22,500 Travere Therapeutics, Inc. shares (Form 4)
Traded May 4 to May 6, 2026 · Filed May 6, 2026
From May 4 to May 6, 2026, Dube Eric M (Director, CHIEF EXECUTIVE OFFICER) sold 22,500 Travere Therapeutics, Inc. shares at US$43.95 for US$989K under a trading plan, leaving 432,886 shares. Filed May 6, 2026 (Form 4).
- Sold
- 22,500 shares
- Price
- US$43.95
- Value
- US$989K
- Holding after
- 432,886 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Option exercise | 22,500 | 455,386 | Direct | |
| May 6, 2026 | Common Stock | Sale | 22,500 | US$43.95 | 432,886 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Dube Eric M
- Travere Therapeutics, Inc. shareholders
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Dube Eric M · Apr 15, 2026
- Form 4 · Dube Eric M · Apr 2, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 12, 2026